Immunotherapy and 18F-FDG PET/CT: standardised procedures are needed
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Link
http://link.springer.com/content/pdf/10.1007/s40336-019-00343-2.pdf
Reference14 articles.
1. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320–330
2. Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A et al (2016) Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 375:1823–1833
3. Cho SY, Lipson EJ, Im HJ, Rowe SP, Gonzalez EM, Blackford A et al (2017) Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma. J Nucl Med 58:1421–1428
4. Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC et al (2018) Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Eur J Nucl Med Mol Imaging 45:376–383
5. Sachpekidis C, Anwar H, Winkler J, Kopp-Schneider A, Larribere L, Haberkorn U et al (2018) The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma. Eur J Nucl Med Mol Imaging 45:1289–1296
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular Imaging Assessment of Immunotherapy Treatment Response;Contemporary Diagnostic Radiology;2023-08-15
2. Molecular Imaging Assessment of Immunotherapy Treatment Response;Contemporary Diagnostic Radiology;2023-08-15
3. Image-guided cancer immunotherapy;Engineering Technologies and Clinical Translation;2022
4. Radiological assessment of response and adverse events associated with novel systemic oncological therapies;Clinical Radiology;2021-04
5. Inmunoterapia, cáncer y PET;Revista Española de Medicina Nuclear e Imagen Molecular;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3